Metoprolol (tartrate)

Confirm delete?

Zoom

Cat No: 21165

Biochemicals - Analytical Standards

Metoprolol (tartrate) (Item No. 21165) is an analytical reference standard categorized as a β1-adrenergic receptor blocker.{25395} This product is intended for use in analytical forensic applications. Metoprolol (succinate) is available as a general r...

This article is not for sale online.
Contact us for more information about this article.

Product Overview
Data
Downloads
About Cayman

Territorial Availability: Available through Bertin Technologies only in France

                                            Technical Warning: Bertin Technologies restricts the sale of this product to licensed controlled substance laboratories and qualified academic research institutions. Please contact us for further details.
                    

                        Special Advice: Please check regulation status before ordering; additionel fees can apply. 
                    

Synonyms:

1-[4-(2-methoxyethyl)phenoxy]-3-[(1-methylethyl)amino]-2-propanol, 2R,3R-dihydroxybutanedioate

Correlated keywords:

51384-51-1 54112-93-5 55250-54-9 60168-92-5 71307-49-8 74220-04-5 129947-83-7 Beloc Betaloc CGP-2175E H-93/26 HCTCGP-2175E Lopresor Metapro Metolar Prelis Seloken Selopral Lopresor Vasocardin CGP2175E H9326 HCTCGP2175E

Product Overview:
Metoprolol (tartrate) (Item No. 21165) is an analytical reference standard categorized as a β1-adrenergic receptor blocker.{25395} This product is intended for use in analytical forensic applications. Metoprolol (succinate) is available as a general research tool (Item No. 15429).

Size	10 mg
Shipping	dry ice
CAS Number	56392-17-7
Molecular Formula	C₁₅H₂₅NO₃ • 1/2C₄H₆O₆
SMILES	COCCC1=CC=C(OCC(O)CNC(C)C)C=C1.OC([C@H](O)[C@@H](O)C(O)=O)=O
Molecular Weight	342,4
Formulation	A crystalline solid
Purity	≥98%
Custom Code	3822.19
UNSPSC code	12352100

Technical File

MSDS

Click here to ask for your quote and get 15% off Cayman's products.

Cayman Chemical's mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.

Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.

Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.

Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.

Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009

Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.